Zilver® PTX® V Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01901289

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01901289
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01901289. Allocation not applicable; no masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2016-11-18 (actual). Results posted on 2018-07-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Zilver® PTX® V Clinical Study
Condition
Peripheral Arterial Disease
Intervention (Device)
Zilver® PTX® Drug-Eluting Peripheral Stent
Lead sponsor
Cook Research Incorporated (class: industry)

Record details

Record id
cardio:ct-nct01901289
Content hash
86c48dca35e3fca31717b034285c6d2babf2d86b772a17c1fb6655da88933a76